ID	Database	Citation
12893990	Pubmed	"UGT pharmacogenomics: implications for cancer risk and cancer therapeutics. Desai AA, Innocenti F, Ratain MJ. Pharmacogenetics. 2003 Aug;13(8):517–23.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/12893990"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/12893990"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/12893990"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
12960109	Pubmed	"Irinotecan pathway genotype analysis to predict pharmacokinetics. Mathijssen RHJ, Marsh S, Karlsson MO, Xie R, Baker SD, Verweij J, et al. Clin Cancer Res. 2003 Aug 15;9(9):3246–53.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/12960109"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/12960109"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/12960109"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
